Z. men_enc vs. | Z. facial vs. | Z. segmental vs. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Control | Z. segmental | Z. facial | Ent. men | Bell’s | Z. segmental | Bell’s | Control | Bell’s | Control | |
(A) Standard CSF parameter | ||||||||||
Leukocyte count | 0.97*** | 0.94*** | 0.63 | 0.68 | 0.96*** | 0.70 | 0.72 | 0.80* | 0.54 | 0.68 |
Protein concentration | 0.81* | 0.67 | 0.62 | 0.62 | 0.73 | 0.52 | 0.59 | 0.69 | 0.61 | 0.68 |
IgG index | 0.74* | 0.62 | 0.60 | 0.66 | 0.90** | 0.51 | 0.77* | 0.58 | 0.83** | 0.63 |
Lactate | 0.86** | 0.82** | 0.71 | 0.70 | 0.88** | 0.67 | 0.75* | 0.74* | 0.65 | 0.65 |
(B) Metabolites | ||||||||||
Best internally validated markera | SM C16:1 | SM C16:1 | PC ae C34.0 | lysoPC a C26:1 | Glycine | PC aa C32:0 | SM(OH) C14:1 | Tryptophan | Arginine | Serine |
AUC | 0.92*** | 0.90*** | 0.83** | 0.87** | 0.96*** | 0.76* | 0.86** | 0.84** | 0.90*** | 0.77* |
(C) Best classifierb | ||||||||||
No. of markers | 2 | 3 | 1 | 2 | 2 | 2 | 3 | 4 | 1 | 3 |
Markers (frequency) | Glycine (1.0) PC aa C30:0 (0.9) | Leukocytes (1.0) SM C16:1 (1.0) total DMA (0.60) | PC ae C34:0 (1.0) | lysoPC a C26:1 (1.0) PC aa C32:0 (1.0) | Leukocytes (1.0) Glycine (1.0) | Leukocytes (0.73) PC aa C32:1 (1.0) | SM(OH) C14:1 (1.0) Glycine (0.96) Tryptophan (1.0) | Tryptophan (1.0) SM(OH) C14:1 (0.71) Leukocytes (1.0) Serine (0.84) | Arginine (1.0) | Serine (1.0) PC ae C36:3 (0.88) Methionine (0.67) |
AUC | 1.00 | 0.95 | 0.83 | 0.90 | 1.00 | 0.77 | 0.92 | 0.86 | 0.90 | 0.86 |
95% CI | 0.87–1.0 | 0.76–1.0 | N/A | 0.57–1.0 | 0.89–1.0 | 0.51–0.91 | 0.61–0.98 | 0.55–0.98 | N/A | 0.53–0.96 |